The 77th Nuremberg International Invention Exhibition in Germany
On November 3rd local time, the 77th International Invention Exhibition (iENA) in Nuremberg, Germany, known as the "Oscar of the Global Invention Industry," came to a successful conclusion.
In this grand event that gathers over 500 top innovative achievements from around the world, the "Newly Designed Bendable Tip Wireless Arthroscope and Soft Tissue Minimally Invasive Suture Instrument" project, led by Professor Li Chunbao's team from the Orthopedic Medicine Department of the Chinese People's Liberation Army General Hospital and jointly developed by research teams such as Suzhou Yingsai Feiying Medical Technology Co., Ltd., has won high recognition from the expert jury for its outstanding technological innovation and industry application value. It stands out from global competitors and has won the highest honor of this exhibition - the gold medal! In addition, the project also received a special award from the Korea Invention Association. With the addition of double awards and international authoritative double certification, it demonstrates the hardcore strength of China's medical innovation.
The International Exhibition of Inventions Nuremberg (iENA), founded in 1948, is one of the world's three major invention exhibitions along with the Geneva International Invention Exhibition and the Pittsburgh International Invention Exhibition, ranking first among them. Due to its fair evaluation, large scale, and cutting-edge technology, it enjoys high authority and reputation in the international exhibition industry!
This exhibition has attracted top inventors, renowned universities, and industry leaders from all over the world to participate, with over 500 exhibits covering cutting-edge technology fields, making the competition extremely fierce.
The Yingsai Feiying team, with the project of "New Flexible Wireless Arthroscopy and Laboureteral Minimally Invasive Suture Device", not only conquered the judging panel composed of international authoritative experts, but also became the focal point of the whole event with the application value of "subverting traditional technological innovation+solving clinical pain points":
01 Wireless design allows doctors to operate without cable entanglement and move freely.
02 The bendable nature of the tip gives arthroscopy a 'nimble finger' that can reach areas of the lesion that are difficult for traditional mirrors to penetrate.
03 Cooperate with minimally invasive stapler to minimize surgical trauma and accelerate patient recovery.
The three core advantages perfectly meet the clinical needs of orthopedics, providing a new solution for the treatment of joint diseases. Its industry breakthrough has been highly praised by the judging panel as a benchmark achievement that combines innovation and practicality.
During the exhibition, the innovative achievements brought by the Yingsai Feiying team have attracted global attention. Research institutions and medical institutions from Germany, the United States, South Korea and other countries have stopped to negotiate and actively seek opportunities for technical cooperation and achievement transformation. This is not only a recognition of individual projects, but also a high level of trust in China's medical innovation capabilities in the international market.
As an innovative enterprise deeply rooted in wireless medical technology, Yingsai Feiying has always been committed to the mission of "driving the progress and development of the medical industry with intelligent wireless technology as the engine" since its establishment. It adheres to the guidance of clinical needs and works together with top research teams to overcome technical difficulties.
The double award won on the iENA stage this time is not only an honor, but also a resounding declaration of China Intelligent Manufacturing's innovative leadership in the field of high-end medical equipment.
In the future, Yingsai Feiying will continue to deeply cultivate the field of minimally invasive medicine, provide Chinese solutions for global patients with more breakthrough achievements, and write innovative international answers for the "Healthy China" strategy.
